Tetramer/BV421 - HLA-A*0201 Influenza-M1 (GILGFVFTL) (REPLACEMENT PRODUCT CODE: TB-0012-4)

  • Code # T01011B
  • Size 50 tests
  • Price Call for Price
Specifications
  • Allele:
    HLA-A*02:01
  • Application:
    FCM
  • Class:
    Class I
  • Conjugate:
    BV421
  • Description:

    The Item Code # for Item T01011B, Tetramer/BV421 - HLA-A*0201 Influenza-M1 (GILGFVFTL), has been changed to Item Code #TB-0012-4.

  • Peptide Sequence:
    GILGFVFTL
  • Product Type:
    Tetramer
  • Research Area:
    Immunology, Immune Monitoring
  • Size:
    50 tests
  • Species Reactivity:
    Human
  • Specificity:
    M1
  • Storage Temperature:
    4°C
  • Target:
    Influenza
Citations
  1. Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
  2. Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
  3. Wong RM, et al. Int Immunol 19: 1223-1234 (2007 BCI)
  4. Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
  5. Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI)
  6. Romano E, et al. Clin. Cancer Res 17: 1984-1997 (2011 BCI) Mantovani S, et al. J Immunol 169: 6253-6260 (2002 BCI)
  7. Aandahl EM. et al. J. Immunol. 170: 2349-2355 (2003 BCI)
  8. Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
  9. Coughlin CM, et al. Blood 103: 2046-2054 (2004 BCI)
  10. Hess C, et al. Blood 104: 3463-3471 (2004 BCI)
  11. Aandahl EM, et al. Blood 104: 3672-3678 (2004 BCI)
  12. Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
  13. Moran TP, et al. J Immunol 175: 3431-3438 (2005 BCI)
  14. Cooper LJN, et al. Blood 105: 1622-1631 (2005 BCI)
  15. Yang S, et al. Clin Cancer Res 11: 5603-5615 (2005 BCI)
  16. Naumov YN, et al. J Immunol 177: 2006-2014 (2006 BCI)
  17. Casati C. et al. Cancer Res. 66: 4450-4460 (2006 BCI)
  18. Zhang H, et al. J Immunol 179: 4910-4918 (2007 BCI)
  19. Naumov YN, et al. J Immunol 181: 7407-7419 (2008)
  20. Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
  21. He X-S, et al. J Infect Dis 197: 803-811 (2008 BCI)
  22. Yu CI, et al. Blood 112: 3671-3678 (2008 BCI)
  23. Turtle CJ, et al. Immunity 31: 834-844 (2009 BCI)
  24. Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI)
  25. Harari A, et al. J Virol 83: 2862-2871 (2009 BCI)
  26. Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
  27. Tu W, et al. J Virol 84: 6527-6535 (2010 BCI)
  28. Ndhlovu ZM, et al. PNAS 107: 3669-3674 (2010 BCI)
  29. Alanio C, et al. Blood 115: 3718-3725 (2010 BCI)
  30. Romano E, et al. Clin Cancer Res 17: 1984-1997 (2011 BCI)
  31. Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
  32. Flamar A-L, et al.J Immunol 189: 2645-2655 (2012 BCI)
  33. Bruns H, et al. Clin Cancer Res 21: 2075-2083 (2015, BCI)